These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9023841)

  • 21. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.
    Braud AC; Gonzague L; Bertucci F; Genre D; Camerlo J; Gravis G; Goncalves A; Moutardier V; Viret F; Maraninchi D; Viens P
    Eur Cytokine Netw; 2002; 13(1):115-20. PubMed ID: 11956030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Gynecologic Oncology Group's role in the treatment of recurrent cervix cancer: current clinical trials.
    Coleman RL;
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S77-80. PubMed ID: 18584855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Medical treatment of metastatic or recurrent cancer of the cervix].
    de la Motte Rouge T; Pautier P; Hamy AS; Duvillard P; Bruna A; Castaigne D; Morice P; Haie-Meder C; Lhommé C
    Bull Cancer; 2006 Mar; 93(3):263-70. PubMed ID: 16567313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy for recurrent cervical carcinoma.
    Moore DH
    Curr Opin Oncol; 2006 Sep; 18(5):516-9. PubMed ID: 16894302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
    Mannel RS; Blessing JA; Boike G
    Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma.
    Hsiao SM; Chen CA; Hsu C; Lin HH; Hsieh CY; Wei LH
    Anticancer Res; 2008; 28(3B):1887-91. PubMed ID: 18630476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinoma of the uterine cervix: current status and future directions.
    Thigpen T; Vance RB; Khansur T
    Semin Oncol; 1994 Apr; 21(2 Suppl 2):43-54; quiz 55, 58. PubMed ID: 8202720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palliative chemotherapy for recurrent and metastatic esophageal cancer.
    Grünberger B; Raderer M; Schmidinger M; Hejna M
    Anticancer Res; 2007; 27(4C):2705-14. PubMed ID: 17695436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy for advanced and recurrent cervical carcinoma: results from cooperative group trials.
    Leath CA; Straughn JM
    Gynecol Oncol; 2013 Apr; 129(1):251-7. PubMed ID: 23280089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
    McMeekin DS; Filiaci VL; Thigpen JT; Gallion HH; Fleming GF; Rodgers WH;
    Gynecol Oncol; 2007 Jul; 106(1):16-22. PubMed ID: 17574073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
    Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM
    J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of metastatic cervical cancer: review of the literature.
    Long HJ
    J Clin Oncol; 2007 Jul; 25(20):2966-74. PubMed ID: 17617528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience.
    Tinker AV; Bhagat K; Swenerton KD; Hoskins PJ
    Gynecol Oncol; 2005 Jul; 98(1):54-8. PubMed ID: 15904950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
    Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antineoplastic chemotherapy for cervical carcinoma (author's transl)].
    Ebeling K; Tanneberger S; Johannsmeyer D
    Zentralbl Gynakol; 1981; 103(17):1023-33. PubMed ID: 6171125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical experience with the chemotherapy of gynecologic cancer].
    Dvorák O; Slavík V; Chmelík V
    Zentralbl Gynakol; 1977; 99(24):1495-501. PubMed ID: 580128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer.
    Tewari KS; Monk BJ
    Curr Oncol Rep; 2005 Nov; 7(6):419-34. PubMed ID: 16221379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy: cisplatin combinations in cervical cancer-which is best?
    Holtz DO; Dunton CJ
    Nat Rev Clin Oncol; 2010 Feb; 7(2):74-5. PubMed ID: 20118975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.